CEOInterviews.AI
Start App
Will Ahmed
Founder & CEO, WHOOP

Whoop CEO Will Ahmed on FDA warning: Our blood pressure insight is intended for wellness use only

📅 Aug 14, 2025 CNBC Television 8 MIN 40186 VIEWS 31 SEGMENTS · 4 SPEAKERS
Will Ahmed, Whoop founder and CEO, joins 'Squawk Box' to discuss FDA's warning letter over the blood pressure feature on its devices. For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://cnb.cx/42d859g » Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision » Subscribe to CNBC: https://cnb.cx/SubscribeCNBC » Watch CNBC on the go with CNBC+: https://www.cnbc.com/WatchCNBCPlus Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide. Connect with CNBC News Online Get...

Questions asked in this interview

9
  1. 0:05And it's good to see you this morning. How are you doing?
  2. 0:31You're in the... what's your number this morning?
  3. 0:43Don't you like to be in the 80s? The 90s?
  4. 0:52The FDA says you can't have that feature on the WHOOP. You say what?
  5. 3:21Is it because they're worried that too many people are going to see blood pressure data and therefore take steps in certain directions around it in inappropriate ways? What is the argument?
  6. 4:30And the question is, how do you think the FDA is going to treat all of this stuff?
  7. 5:39By the way, have you talked to, like, RFK about this?
  8. 6:23This doesn't actually deeply reflect the current administration as much as it does what is the overall policy in the United States for innovation and for giving Americans access to health data?
  9. 7:04Have you found that doctors in America are taking your data more seriously?
Narrator 0:00 ↗
CNBC.com. Wealth.
Andrew 0:05 ↗
Now to a topic near and dear to many of our viewers. Those are wearable health devices. Last month, the FDA issued a warning letter to WHOOP over the blood pressure feature on its device. Now, today, WHOOP CEO Will Ahmed is joining us exclusively with a response to the FDA. And it's good to see you this morning. How are you doing?
Will Ahmed 0:28 ↗
Good to see you, Andrew. I'm in the green, so I'm ready for you.
Andrew 0:31 ↗
Well, thank you. You're in the... what's your number this morning?
Will Ahmed 0:36 ↗
71%.
Andrew 0:36 ↗
That's low, dude.
Will Ahmed 0:39 ↗
It's a green recovery. That's actually quite good. Thank you.
Andrew 0:43 ↗
Don't you like to be in the 80s? The 90s?
Will Ahmed 0:46 ↗
Well, it's because I trained so hard yesterday. You know, you go up and down. That's, you know, that's how these things go.
Andrew 0:52 ↗
Okay, so tell us what's going on here. Because for those in the audience who may not understand what's happening, you had a feature on the WHOOP. The FDA says you can't have that feature on the WHOOP. You say what?
Will Ahmed 1:06 ↗
Well, just this week, we've pushed back on the FDA's claim that Blood Pressure Insights is a medical device and should be regulated. As a little background for your audience, WHOOP spent the last three years, tens of millions of dollars innovating in the space and coming out with Blood Pressure Insights, which allows you to use your WHOOP to get a daily estimate of your blood pressure after doing a cuff calibration. And in turn, this feature will allow you to understand your blood pressure alongside a variety of wellness information. So alongside sleep, alongside exercise, alongside nutrition. And this is really pretty consistent with what the 21st Century Cures Act outlines as intended use. If a product or a feature is intended for wellness, it is not designed to be regulated by the FDA. The FDA's mandate is to regulate medical features that have a diagnosis, and you can see this with other physiological metrics where there's a wellness use case and a medical use case. So, for example, with heart rate, you know, heart rates existed, heart rate monitoring existed since the 80s with products like the Polar chest strap and others. WHOOP does heart rate. Apple Watch does heart rate. Okay. If you do heart rate for exercise, heart rate for sleep, heart rate for stress, that's all wellness. If you want to detect that someone's got AFib, okay, that's medical diagnosis that needs to be cleared by the FDA. And just to be clear, like, we're pretty familiar with these different territories. Like, we've done heart rate monitoring and wellness. And actually in the last two and a half years, we worked with the FDA, we did clinical trials, and now WHOOP has a medically cleared feature as well: ECG monitoring to detect AFib. So there's pretty clear lines of distinction for a number of physiological metrics. But for some reason, for blood pressure, the FDA says that there can't be a wellness use case. And that doesn't make a lot of sense, because there's an avalanche of peer-reviewed research that shows that blood pressure, not surprisingly, impacts your wellness.
Andrew 3:21 ↗
So, Will, what do you think is happening here? Do you think there's an effort by the FDA to protect device makers who make blood pressure devices? Is it because they're worried that too many people are going to see blood pressure data and therefore take steps in certain directions around it in inappropriate ways? What is the argument?
Will Ahmed 3:43 ↗
Well, just to be clear, like, we have a lot of respect for the FDA. I think the role that they play is pretty critical in society, and we've worked with the FDA on a number of different features. I think just in this specific case, they've got it wrong. And it's in part because this is all new technology. You know, historically, you could only really measure blood pressure with a cuff. WHOOP is one of the first wearables in the world that can provide an accurate estimate from the wrist. So that's fairly unique. And you have to, you know, overcome past precedent in your analysis of that. But I think this is a bigger theme, which is, you know, what are the policies in this country that enable technology companies like WHOOP to innovate and as good.
Andrew 4:30 ↗
Well, I was just going to say the bigger issue, which I think is where you're going, is all of this stuff is going to start to converge, right? And by the way, we saw this whole issue play out in a very unique way in the hearing aid business, for example. Right. There were lots of folks who wanted to get into that space, make it effectively a consumer product, or AirPod was going to be. It could be a hearing aid, effectively, if you wanted it to be. Could you really say that it wasn't? I mean, I think all of these devices that are sort of quasi-pro-consumer come together at some point. And the question is, how do you think the FDA is going to treat all of this stuff?
Will Ahmed 5:09 ↗
I think it's important that there's just consistent policies and consistent treatment. The 21st Century Cures Act makes it very clear that features that are intended for wellness are not supposed to be regulated by the FDA, and the FDA should follow that guideline, which is the law. And we've seen the FDA do this successfully with things like heart rate and pulse ox and skin temperature and sleep and respiratory rate. And so in the case of blood pressure, there should be a wellness use case. And that's what WHOOP has put forwards.

15 more exchanges in this transcript

Sign in free to read the rest of this interview. No card required.

Sign in to read the full transcript

Cite this transcript

APA, MLA, BibTeX
APA

Ahmed, W. (2025, August 14). Whoop CEO Will Ahmed on FDA warning: Our blood pressure insight is intended for wellness use only [Interview transcript]. CNBC Television. CEOInterviews.AI. https://ceointerviews.ai/interview/3164436/

MLA

Will Ahmed. "Whoop CEO Will Ahmed on FDA warning: Our blood pressure insight is intended for wellness use only." CNBC Television, 14 Aug. 2025. Transcript, CEOInterviews.AI, https://ceointerviews.ai/interview/3164436/.

BibTeX
@misc{ahmed2025_3164436,
  author       = {Will Ahmed},
  title        = {Whoop CEO Will Ahmed on FDA warning: Our blood pressure insight is intended for wellness use only},
  howpublished = {Interview transcript, CNBC Television. CEOInterviews.AI},
  year         = {2025},
  month        = {aug},
  url          = {https://ceointerviews.ai/interview/3164436/},
  note         = {Speaker-attributed transcript with timestamps}
}